STAT3 in the systemic inflammation of cancer cachexia.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Seminars in Cell and Developmental Biology

• Publication date

  2016-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.semcdb.2016.02.009PMID 26860754PMCID PMC4867234
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Protein breakdown in cancer cachexia.

  2016cited by this paper
• Constitutive activation of STAT3 in breast cancer cells: A review

  2016cited by this paper
• Lipolytic and thermogenic depletion of adipose tissue in cancer cachexia.

  2016cited by this paper
• Impaired regeneration: A role for the muscle microenvironment in cancer cachexia.

  2016cited by this paper
• The central role of hypothalamic inflammation in the acute illness response and cachexia.

  2016cited by this paper
• Computed tomography-defined muscle and fat wasting are associated with cancer clinical outcomes.

  2016cited by this paper
• Malignant Drosophila tumors interrupt insulin signaling to induce cachexia-like wasting.

  2015cited by this paper
• Treatment of cachexia: An overview of recent developments.

  2015cited by this paper
• Inflammation induced loss of skeletal muscle.

  2015cited by this paper
• Deletion of Stat3 in hematopoietic cells enhances thrombocytosis and shortens survival in a JAK2-V617F mouse model of MPN.

  2015cited by this paper
• Role of Activin A and myostatin in human cancer cachexia.

  2015cited by this paper
• Gain‐of‐function STAT1 mutations impair STAT3 activity in patients with chronic mucocutaneous candidiasis (CMC)

  2015cited by this paper
• IL-6 as a keystone cytokine in health and disease

  2015cited by this paper
• Enhanced miR-210 expression promotes the pathogenesis of endometriosis through activation of signal transducer and activator of transcription 3.

  2015cited by this paper
• Tocilizumab for treating rheumatoid arthritis: an evaluation of pharmacokinetics/pharmacodynamics and clinical efficacy

  2015cited by this paper
• Inhibition of Stat3 Activation Suppresses Caspase-3 and the Ubiquitin-Proteasome System, Leading to Preservation of Muscle Mass in Cancer Cachexia*

  2015cited by this paper
• Systematic review of anaemia and inflammatory markers in chronic obstructive pulmonary disease

  2015cited by this paper
• MAP3K11/GDF15 axis is a critical driver of cancer cachexia

  2015cited by this paper
• Contribution of Neuroinflammation to the Pathogenesis of Cancer Cachexia

  2015cited by this paper
• Knockout of STAT3 in skeletal muscle does not prevent high-fat diet-induced insulin resistance

  2015cited by this paper
• Early-onset lymphoproliferation and autoimmunity caused by germline STAT3 gain-of-function mutations.

  2015cited by this paper
• Liver Inflammation and Metabolic Signaling in ApcMin/+ Mice: The Role of Cachexia Progression

  2015cited by this paper
• Anamorelin hydrochloride for the treatment of cancer-anorexia-cachexia in NSCLC

  2015cited by this paper
• Opposing roles of STAT1 and STAT3 in IL-21 function in CD4+ T cells

  2015cited by this paper
• Cachexia and sarcopenia: mechanisms and potential targets for intervention.

  2015cited by this paper
• The IL-6/gp130/STAT3 signaling axis: recent advances towards specific inhibition.

  2015cited by this paper
• The Sick and the Weak: Neuropathies/Myopathies in the Critically Ill.

  2015cited by this paper
• Sex differences in the relationship of IL-6 signaling to cancer cachexia progression.

  2015cited by this paper
• Preclinical Investigation of the Novel Histone Deacetylase Inhibitor AR-42 in the Treatment of Cancer-Induced Cachexia.

  2015cited by this paper
• Mutations leading to constitutive active gp130/JAK1/STAT3 pathway.

  2015cited by this paper
• Signal Transducer and Activator of Transcription 3, Mediated Remodeling of the Tumor Microenvironment Results in Enhanced Tumor Drug Delivery in a Mouse Model of Pancreatic Cancer.

  2015cited by this paper
• Systemic organ wasting induced by localized expression of the secreted insulin/IGF antagonist ImpL2.

  2015cited by this paper
• Plasma growth differentiation factor 15 is associated with weight loss and mortality in cancer patients

  2015cited by this paper
• A Key Role for Leukemia Inhibitory Factor in C26 Cancer Cachexia*

  2015cited by this paper
• TCGA data and patient-derived orthotopic xenografts highlight pancreatic cancer-associated angiogenesis

  2015cited by this paper
• STAT3 acts through pre-existing nucleosome-depleted regions bound by FOS during an epigenetic switch linking inflammation to cancer

  2015cited by this paper
• Cardiac and skeletal muscles show molecularly distinct responses to cancer cachexia.

  2015cited by this paper
• STAT3 signaling controls satellite cell expansion and skeletal muscle repair

  2014cited by this paper
• STAT3 in hepatocellular carcinoma: new perspectives.

  2014cited by this paper
• STAT3, a key regulator of cell-to-cell communication in the heart.

  2014cited by this paper
• Prolyl-4-hydroxylase α subunit 2 promotes breast cancer progression and metastasis by regulating collagen deposition

  2014cited by this paper
• Role of interleukin-6 in cachexia: therapeutic implications

  2014cited by this paper
• Integration of genome-wide of Stat3 binding and epigenetic modification mapping with transcriptome reveals novel Stat3 target genes in glioma cells.

  2014cited by this paper
• Clinical Classification of Cancer Cachexia: Phenotypic Correlates in Human Skeletal Muscle

  2014cited by this paper
• A switch from white to brown fat increases energy expenditure in cancer-associated cachexia.

  2014cited by this paper
• Stat3 promotes IL-10 expression in lupus T cells through trans-activation and chromatin remodeling

  2014cited by this paper
• Siltuximab for multicentric Castleman's disease: a randomised, double-blind, placebo-controlled trial.

  2014cited by this paper
• STAT3 Activity and Function in Cancer: Modulation by STAT5 and miR-146b

  2014cited by this paper
• One-year prevalence, comorbidities and cost of cachexia-related inpatient admissions in the USA

  2014cited by this paper
• Genetic basis of interindividual susceptibility to cancer cachexia: selection of potential candidate gene polymorphisms for association studies

  2014cited by this paper
• Inhibition of JAK/STAT signaling stimulates adult satellite cell function

  2014cited by this paper
• Modulation of vascular smooth muscle cell phenotype by STAT-1 and STAT-3.

  2014cited by this paper
• Depletion of White Adipose Tissue in Cancer Cachexia Syndrome Is Associated with Inflammatory Signaling and Disrupted Circadian Regulation

  2014cited by this paper
• Treatment of cachexia: an overview of recent developments.

  2014cited by this paper
• Sunitinib prevents cachexia and prolongs survival of mice bearing renal cancer by restraining STAT3 and MuRF-1 activation in muscle

  2014cited by this paper
• A Small Molecule Compound Targeting STAT3 DNA-Binding Domain Inhibits Cancer Cell Proliferation, Migration, and Invasion

  2014cited by this paper
• Skeletal muscle glycoprotein 130's role in Lewis lung carcinoma–induced cachexia

  2014cited by this paper
• STAT3 Induction of miR-146b Forms a Feedback Loop to Inhibit the NF-κB to IL-6 Signaling Axis and STAT3-Driven Cancer Phenotypes

  2014cited by this paper
• Muscle wasting in disease: molecular mechanisms and promising therapies

  2014cited by this paper
• Bioinformatics analysis of molecular mechanisms of chronic obstructive pulmonary disease.

  2014cited by this paper
• Formoterol in the treatment of experimental cancer cachexia: effects on heart function

  2014cited by this paper
• Genome-wide identification of FoxO-dependent gene networks in skeletal muscle during C26 cancer cachexia

  2014cited by this paper
• The Role of STAT3 in Non-Small Cell Lung Cancer

  2014cited by this paper
• Critical Role for Lysine 685 in Gene Expression Mediated by Transcription Factor Unphosphorylated STAT3*

  2014cited by this paper
• Combined STAT3 and BCR-ABL1 Inhibition Induces Synthetic Lethality in Therapy-Resistant Chronic Myeloid Leukemia

  2014cited by this paper
• Pancreatic Cancer‐Induced Cachexia Is Jak2‐Dependent in Mice

  2014cited by this paper
• Galiellalactone Is a Direct Inhibitor of the Transcription Factor STAT3 in Prostate Cancer Cells*♦

  2014cited by this paper
• Rosiglitazone reduces body wasting and improves survival in a rat model of cancer cachexia.

  2014cited by this paper
• Interleukin-6: a villain in the drama of pancreatic cancer development and progression.

  2014cited by this paper
• STAT3 inhibition sensitizes colorectal cancer to chemoradiotherapy in vitro and in vivo

  2014cited by this paper
• Signal Integration and Gene Induction by a Functionally Distinct STAT3 Phosphoform

  2014cited by this paper
• STATs profiling reveals predominantly‐activated STAT3 in cholangiocarcinoma genesis and progression

  2014cited by this paper
• Cardiovascular function and predictors of exercise capacity in patients with colorectal cancer.

  2014cited by this paper
• Targeting JAK1/STAT3 Signaling Suppresses Tumor Progression and Metastasis in a Peritoneal Model of Human Ovarian Cancer

  2014cited by this paper
• Pharmacologic Management of Human Immunodeficiency Virus Wasting Syndrome

  2014cited by this paper
• Leptin signaling

  2014cited by this paper
• Molecular mechanisms and treatment targets of muscle wasting and cachexia in heart failure: an overview

  2014cited by this paper
• Concurrent evolution of cancer cachexia and heart failure: bilateral effects exist

  2014cited by this paper
• Oxidative and proteolytic profiles of the right and left heart in a model of cancer-induced cardiac cachexia.

  2014cited by this paper
• Revisiting STAT3 signalling in cancer: new and unexpected biological functions

  2014cited by this paper
• Genetic modulation of the interleukin 6 (IL-6) system in patients with advanced gastric cancer: a background for an alternative target therapy

  2014cited by this paper
• Metabolic impairment in heart failure: the myocardial and systemic perspective.

  2014cited by this paper
• Novel Role for Tumor-Induced Expansion of Myeloid-Derived Cells in Cancer Cachexia

  2014cited by this paper
• JAK-STAT and feeding

  2013cited by this paper
• NF-κB-mediated Pax7 dysregulation in the muscle microenvironment promotes cancer cachexia.

  2013cited by this paper
• Signal Transducer and Activator of Transcription 3 (STAT3) Regulates Collagen-Induced Platelet Aggregation Independently of Its Transcription Factor Activity

  2013cited by this paper
• A literature review of end-stage renal disease and cachexia: understanding experience to inform evidence-based healthcare.

  2013cited by this paper
• Gut barrier dysfunction and microbial translocation in cancer cachexia: a new therapeutic target

  2013cited by this paper
• The role of Stat3 in glioblastoma multiforme.

  2013cited by this paper
• Pancreatic cancer-associated stellate cells

  2013cited by this paper
• AZD1480: a phase I study of a novel JAK2 inhibitor in solid tumors.

  2013cited by this paper
• TSC22D4 is a molecular output of hepatic wasting metabolism

  2013cited by this paper
• Dancing rhinos in stilettos

  2013cited by this paper
• gp130: a promising drug target for cancer therapy

  2013cited by this paper
• The mechanisms of cachexia underlying muscle dysfunction in COPD.

  2013cited by this paper
• Distinct transcriptional regulatory modules underlie STAT3’s cell type-independent and cell type-specific functions

  2013cited by this paper
• Potent Targeting of the STAT3 Protein in Brain Cancer Stem Cells: A Promising Route for Treating Glioblastoma.

  2013cited by this paper
• Pancreatic cancer-associated stellate cells promote differentiation of myeloid-derived suppressor cells in a STAT3-dependent manner.

  2013cited by this paper
• STAT3 activation in response to IL-6 is prolonged by the binding of IL-6 receptor to EGF receptor

  2013cited by this paper
• Why cachexia kills: examining the causality of poor outcomes in wasting conditions

  2013cited by this paper

• NF-κB Signaling as a Central Driver of Cancer Cachexia.

  2026cites this paper
• The Vesicular Intersection Layer: A Framework for Cross-Kingdom Extracellular Vesicle Signaling That May Connect Gut Dysbiosis to Skeletal Muscle Wasting in Colorectal Cancer Cachexia

  2026cites this paper
• Cancer cachexia: molecular basis and therapeutic advances

  2026cites this paper
• Pre-cachectic changes in amino acid homeostasis precede activation of eIF2α signaling in the liver at the onset of C26 cancer-induced cachexia

  2025cites this paper
• Tomatidine Attenuates Inflammatory Responses to Exercise-Like Stimulation in Donor-derived Skeletal Muscle Myobundles.

  2025cites this paper
• Coptis japonica Makino ethanol extracts attenuates cancer cachexia induced muscle and fat wasting through inhibition of the STAT3 signaling pathway

  2025cites this paper
• Cancer Cachexia.

  2025cites this paper
• B0092 tumor-bearing mice are a new model for the study of cachexia in head and neck cancer.

  2025cites this paper
• Sex impacts inflammatory signaling, body composition, and physical function in tumor-bearing mice receiving chemotherapy.

  2025cites this paper
• Cold, Hot, and Lethal—The Tumour Microenvironment and the Immunology of Head and Neck Squamous Cell Carcinoma

  2025cites this paper
• Immunotherapy of small cell lung cancer based on prognostic nutritional index

  2025cites this paper
• Comprehensive transcriptomic analysis identifies Lrg1 as a potential therapeutic target for preventing muscle atrophy in cancer cachexia.

  2025cites this paper
• An Iron-regulated Signalling Pathway Controls Adipose Browning and Cancer Cachexia

  2025cites this paper
• Functional liver genomics identifies hepatokines promoting wasting in cancer cachexia.

  2025cites this paper
• Association between Geriatric Nutritional Risk Index and survival outcomes in patients with urological cancers: an updated meta-analysis

  2025cites this paper
• Cachexia‐induced reprogramming of visceral organ metabolism by human pancreatic cancer xenografts

  2025cites this paper
• Muscle Mechanics in Metabolic Health and Longevity: The Biochemistry of Training Adaptations

  2025cites this paper
• Unraveling the role of STAT3 in Cancer Cachexia: pathogenic mechanisms and therapeutic opportunities

  2025cites this paper
• mtSTAT3 suppresses rheumatoid arthritis by regulating Th17 and synovial fibroblast inflammatory cell death with IL-17-mediated autophagy dysfunction

  2025cites this paper
• Pan-cancer secreted proteome and skeletal muscle regulation: insight from a proteogenomic data-driven knowledge base

  2025cites this paper
• Hepatic signal transducer and activator of transcription‐3 signalling drives early‐stage pancreatic cancer cachexia via suppressed ketogenesis

  2024cites this paper
• Extracellular vesicles in cancer cachexia: deciphering pathogenic roles and exploring therapeutic horizons

  2024cites this paper
• Brassinin alleviates cancer cachexia by suppressing diverse inflammatory mechanisms in mice

  2024cites this paper
• Cardioprotection of voluntary exercise against breast cancer-induced cardiac injury via STAT3

  2024cites this paper
• Crosstalk between CXCL12/CXCR4/ACKR3 and the STAT3 Pathway

  2024cites this paper
• Sex-Related Differences in Pancreatic Ductal Adenocarcinoma Progression and Response to Therapy

  2024cites this paper
• The role of interleukin‐6 family cytokines in cancer cachexia

  2024cites this paper
• Attenuation of esophageal anastomotic stricture through remote ischemic conditioning in a rat model

  2024cites this paper
• Astaxanthin Ameliorates Skeletal Muscle Atrophy in Mice With Cancer Cachexia

  2024cites this paper
• Compartmentalized role of xCT in supporting pancreatic tumor growth, inflammation and mood disturbance in mice.

  2024cites this paper
• Metabolic diagnosis of cancer cachexia

  2024cites this paper
• Celecoxib attenuates hindlimb unloading-induced muscle atrophy via suppressing inflammation, oxidative stress and ER stress by inhibiting STAT3

  2024cites this paper
• JNK Kinase regulates cachexia like syndrome in scribble knockdown tumor model of Drosophila melanogaster.

  2024cites this paper
• Paeoniflorin alleviated muscle atrophy in cancer cachexia through inhibiting TLR4/NF-κB signaling and activating AKT/mTOR signaling.

  2024cites this paper
• Extracellular Vesicles and Exosomes in the Control of the Musculoskeletal Health

  2024cites this paper
• Transcriptional Analysis of Cancer Cachexia: Conserved and Unique Features Across Pre-Clinical Models and Biological Sex.

  2024cites this paper
• Skeletal muscle omics signatures in cancer cachexia: perspectives and opportunities.

  2023cites this paper
• Diabetes increases mortality in patients with pancreatic and colorectal cancer by promoting cachexia and its associated inflammatory status

  2023cites this paper
• Cucurbitacin IIb attenuates cancer cachexia induced skeletal muscle atrophy by regulating the IL‐6/STAT3/FoxO signaling pathway

  2023cites this paper
• Babao Dan Alleviates Cancer Cachexia in Mice Via Inhibiting IL-6/STAT3 Signaling Pathway

  2023cites this paper
• Pretreatment with Eupatilin Attenuates Inflammation and Coagulation in Sepsis by Suppressing JAK2/STAT3 Signaling Pathway

  2023cites this paper
• Current advancements in pharmacotherapy for cancer cachexia

  2023influential citation
• The time-course of cancer cachexia onset reveals biphasic transcriptional disruptions in female skeletal muscle distinct from males

  2023cites this paper
• Prognostic value of various nutritional risk markers in patients hospitalized for the treatment of genitourinary cancer: A retrospective study.

  2023cites this paper
• Inflammation o'clock: interactions of circadian rhythms with inflammation‐induced skeletal muscle atrophy

  2023cites this paper
• Treatment of cancer cachexia with exercise

  2023cites this paper
• Cancer cachexia: molecular mechanisms and treatment strategies

  2023cites this paper
• STAT3 Signalling Drives LDH Up-Regulation and Adiponectin Down-Regulation in Cachectic Adipocytes

  2023cites this paper
• Cancer cachexia: Focus on cachexia factors and inter-organ communication

  2023cites this paper
• Detecting the vitamin D receptor (VDR) protein in mouse and human skeletal muscle: Strain-specific, species-specific and inter-individual variation.

  2023cites this paper
• FK506 bypasses the effect of erythroferrone in cancer cachexia skeletal muscle atrophy

  2023cites this paper
• Small non‐coding RNA profiling in patients with gastrointestinal cancer

  2023cites this paper
• Systemic Reprogramming of Endothelial Cell Signaling in Metastasis and Cachexia

  2022cites this paper
• The critical role of STAT3 in biogenesis of tumor-derived exosomes with potency of inducing cancer cachexia in vitro and in vivo

  2022cites this paper
• Saikosaponin D alleviates cancer cachexia by directly inhibiting STAT3

  2022cites this paper
• Impaired Barrier Integrity of the Skeletal Muscle Vascular Endothelium Drives Progression of Cancer Cachexia

  2022cites this paper
• Multi-omics profiling reveals Chitinase-3-like protein 1 as a key mediator in the crosstalk between sarcopenia and liver cancer

  2022cites this paper
• The role of IL-6/JAK2/STAT3 signaling pathway in cancers

  2022cites this paper
• Less Well-Known Consequences of the Long-Term Use of Opioid Analgesics: A Comprehensive Literature Review

  2022cites this paper
• The Time-Course of Cancer Cachexia Onset Reveals Biphasic Transcriptional Disruptions in Female Skeletal Muscle Distinct from Males

  2022cites this paper
• Ginsenoside Rd ameliorates muscle wasting by suppressing the signal transducer and activator of transcription 3 pathway

  2022cites this paper
• 2-Deoxy-D-glucose Alleviates Cancer Cachexia-Induced Muscle Wasting by Enhancing Ketone Metabolism and Inhibiting the Cori Cycle

  2022cites this paper
• Metastatic or xenograft colorectal cancer induce divergent anabolic deficits and pro-inflammatory effectors of muscle wasting in a tumor-type dependent manner.

  2022cites this paper
• Pyruvate prevents the onset of the cachectic features and metabolic alterations in myotubes downregulating STAT3 signaling

  2022cites this paper
• Network pharmacology and molecular docking analysis reveal insights into the molecular mechanism of shiliao decoction in the treatment of cancer-associated malnutrition

  2022cites this paper
• Exogenous Oncostatin M induces Cardiac Dysfunction, Musculoskeletal Atrophy, and Fibrosis.

  2022cites this paper
• Overexpression of miR-125a-5p Inhibits Hepatocyte Proliferation through the STAT3 Regulation In Vivo and In Vitro

  2022cites this paper
• Cancer cachexia: a nutritional or a systemic inflammatory syndrome?

  2022cites this paper
• Cancer cachexia as a multiorgan failure: Reconstruction of the crime scene

  2022cites this paper
• P2Y1R and P2Y2R: potential molecular triggers in muscle regeneration

  2022cites this paper
• Expression of LncRNAs in HPV-induced Carcinogenesis and Cancer Cachexia: A Study in K14-HPV16 Mice

  2022cites this paper
• microRNA-181a Promotes Mitochondrial Dysfunction and Inflammatory Reaction in a Rat Model of Intensive Care Unit-Acquired Weakness by Inhibiting IGFBP5 Expression.

  2022cites this paper
• Interleukin‐6 initiates muscle‐ and adipose tissue wasting in a novel C57BL/6 model of cancer‐associated cachexia

  2022cites this paper
• Cancer- and cardiac-induced cachexia: same fate through different inflammatory mediators?

  2022cites this paper
• Insights into the role of STAT3 in intrahepatic cholangiocarcinoma

  2022cites this paper
• Sex specificity of pancreatic cancer cachexia phenotypes, mechanisms, and treatment in mice and humans: role of Activin

  2022cites this paper
• Less Well-Known Consequences of the Long-Term Use of Opioid Analgesics: A Comprehensive Literature Review

  2022cites this paper
• Growth differentiation factor 11 induces skeletal muscle atrophy via a STAT3-dependent mechanism in pulmonary arterial hypertension

  2022cites this paper
• Atractylenolide I ameliorates cancer cachexia through inhibiting biogenesis of IL‐6 and tumour‐derived extracellular vesicles

  2022cites this paper
• Cancer-Related Cachexia: The Vicious Circle between Inflammatory Cytokines, Skeletal Muscle, Lipid Metabolism and the Possible Role of Physical Training

  2022cites this paper
• Therapeutic Influence on Important Targets Associated with Chronic Inflammation and Oxidative Stress in Cancer Treatment

  2021cites this paper
• Bile Acid Dysregulation Is Intrinsically Related to Cachexia in Tumor-Bearing Mice

  2021cites this paper
• The prevalence of sarcopenia and relationships between dietary intake and muscle mass in head and neck cancer patients undergoing radiotherapy: A longitudinal study.

  2021cites this paper
• Profiling of Matched Adipose and Skeletal Muscle in Human Pancreatic Cancer Cachexia Reveals Distinct Gene Profiles with Convergent Pathways

  2021cites this paper
• Immunopathogenic mechanisms of rheumatoid arthritis and the use of anti-inflammatory drugs.

  2021cites this paper
• Profiling of Adipose and Skeletal Muscle in Human Pancreatic Cancer Cachexia Reveals Distinct Gene Profiles with Convergent Pathways

  2021cites this paper
• Human Brown Adipose Tissue and Metabolic Health: Potential for Therapeutic Avenues

  2021cites this paper
• Non-toxic sulfur inhibits LPS-induced inflammation by regulating TLR-4 and JAK2/STAT3 through IL-6 signaling

  2021cites this paper
• Pre-clinical investigation of STAT3 pathway in bladder cancer: Paving the way for clinical translation.

  2021cites this paper
• Cancer cachexia: molecular mechanism and pharmacological management.

  2021cites this paper
• Low-Dose Metformin as a Monotherapy Does Not Reduce Non-Small-Cell Lung Cancer Tumor Burden in Mice

  2021cites this paper
• STAT3 but Not ERK2 Is a Crucial Mediator Against Diet-Induced Obesity via VMH Neurons

  2021cites this paper
• Relationship of Cachexia with Self-Care Agency and Quality of Life in Cancer Patients: The Case of Turkey

  2021cites this paper
• Role of autophagy in muscle disease.

  2021cites this paper
• Inhibition of heat shock protein (HSP) 90 reverses signal transducer and activator of transcription (STAT) 3‐mediated muscle wasting in cancer cachexia mice

  2021cites this paper
• Cancer-Mediated Muscle Cachexia: Etiology and Clinical Management.

  2021cites this paper
• Understanding the common mechanisms of heart and skeletal muscle wasting in cancer cachexia

  2021cites this paper
• Emerin Represses STAT3 Signaling through Nuclear Membrane-Based Spatial Control

  2021cites this paper
• A Novel Role of Bergamottin in Attenuating Cancer Associated Cachexia by Diverse Molecular Mechanisms

  2021cites this paper
• Understanding the biology of volumetric muscle loss for an individualized exercise rehabilitation approach in breast cancer patients.

  2021cites this paper